Results 1-101 of 101 (Search time: 0.013 seconds).
Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link | |
---|---|---|---|---|---|---|---|
1 | 2023 | Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel | Chiu, Joanne Wing Yan; Lee, Soo Chin; Ho, James Chung-Man; Park, Yeon Hee; Chao, Ta-Chung; Kim, Sung-Bae; Lim, Elgene; CHING-HUNG LIN ; Loi, Sherene; Low, Su Ying; Teo, Lynette Li San; Yeo, Winnie; Dent, Rebecca | Drug safety | 2 | 0 | |
2 | 2023 | Disparity in survival benefits of pembrolizumab between Asian and non-Asian patients with advanced cancers: A systematic review and meta-regression analysis | Peng, Shang-Hsuan; CHING-HUNG LIN ; I-CHUN CHEN ; YING-CHUN SHEN ; DWANG-YING CHANG ; WEI-WU CHEN ; Huang, Shu-Min; Hu, Fu-Chang; YEN-SHEN LU | Cancer medicine | 0 | 0 | |
3 | 2023 | Lifestyle Factors and Energy Intakes with Risks of Breast Cancer among Pre- and Post- Menopausal Women in Taiwan | Huang, Meng-Chuan; Huang, Tz-Ting; Feng, Hsin-Chun; I-CHUN CHEN ; Chang, Chiao-I; Wang, Tsu-Nai; WEN-HUNG KUO ; Wang, Ming-Yang; LI-WEI TSAI ; Li, Szu-Yi; Huang, Chiun-Sheng; YEN-SHEN LU ; CHING-HUNG LIN | Nutrients | 1 | ||
4 | 2023 | Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer | WEI-WU CHEN ; Hsiao, Wen; Dai, Ming-Shen; CHING-HUNG LIN ; DWANG-YING CHANG ; I-CHUN CHEN ; MING-YANG WANG ; Chang, Shu-Han; Huang, Shu-Min; ANN-LII CHENG ; Wu, Ko-Wen; Tan, Kien Thiam; YEN-SHEN LU | Breast cancer research and treatment | 0 | 0 | |
5 | 2023 | Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer | Im, S-A; Gennari, A; Park, Y H; Kim, J H; Jiang, Z-F; Gupta, S; Fadjari, T H; Tamura, K; Mastura, M Y; Abesamis-Tiambeng, M L T; Lim, E H; CHING-HUNG LIN ; Sookprasert, A; Parinyanitikul, N; Tseng, L-M; Lee, S-C; Caguioa, P; Singh, M; Naito, Y; Hukom, R A; Smruti, B K; Wang, S-S; Kim, S B; Lee, K-H; Ahn, H K; Peters, S; Kim, T W; Yoshino, T; Pentheroudakis, G; Curigliano, G; Harbeck, N | ESMO open | 4 | 1 | |
6 | 2023 | Estrogen-DNA Adducts and Breast Cancer Risk in Premenopausal Asian Women | CHING-HUNG LIN ; Zahid, Muhammad; WEN-HUNG KUO ; Hu, Fu-Chang; MING-YANG WANG ; I-CHUN CHEN ; Beseler, Cheryl L; Mondal, Bodhisattwa; YEN-SHEN LU ; Rogan, Eleanor G; ANN-LII CHENG | Cancer prevention research (Philadelphia, Pa.) | 0 | 0 | |
7 | 2023 | Deep-learning based breast cancer detection for cross-staining histopathology images | Huang, Pei-Wen; Ouyang, Hsu; Hsu, Bang-Yi; Chang, Yu-Ruei; Lin, Yu-Chieh; Chen, Yung-An; Hsieh, Yu-Han; Fu, Chien-Chung; Li, Chien-Feng; CHING-HUNG LIN ; Lin, Yen-Yin; Dah-Tsyr Chang, Margaret; Pai, Tun-Wen | Heliyon | 4 | 2 | |
8 | 2023 | Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma | HUANG-CHUN LIEN ; Hsu, Chia-Lang; YEN-SHEN LU ; WEI-WU CHEN ; I-CHUN CHEN ; Li, Yu-Chia; CHIUN-SHENG HUANG ; ANN-LII CHENG ; CHING-HUNG LIN | Breast cancer research : BCR | 1 | 0 | |
9 | 2022 | Clinical Outcomes of Metastatic Breast Cancer in Patients Having Imaging Liver Pseudocirrhosis with or without Evident Varices | WEI-LI MA ; DWANG-YING CHANG ; CHING-HUNG LIN ; KAO-LANG LIU ; PO-CHIN LIANG ; HUANG-CHUN LIEN ; Hu, Chan-Chuan; Huang, Ling-Yun; Yeh, Yi-Chun; YEN-SHEN LU | The oncologist | 0 | 1 | |
10 | 2022 | Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients | PO-HAN LIN ; Chen, Shin-Cheh; Tseng, Ling-Ming; KING-JEN CHANG ; Huang, Ai-Chu; Cheng, Kuo-Chih; Yang, Karen; Wu, Hui-Chen; Chao, Tsu-Yi; Chang, Yuan-Ching; Lin, Peng-Chan; WEN-HUNG KUO ; Kuo, Wen-Lin; CHING-HUNG LIN ; Chen, Huo-Mu; Yeh, Dah-Cherng; Liu, Liang-Chih; Liu, Chun-Yu; MING-YANG WANG ; Chiao Lo ; YEN-SHEN LU ; CHIUN-SHENG HUANG | Breast cancer research and treatment | 5 | 4 | |
11 | 2022 | Development of an LC-MS/MS method to simultaneously quantify therapeutic mAbs and estimate hematocrit values in dried blood spot samples | Chiu, Huai-Hsuan; Tsai, Yun-Jung; Chiao Lo ; Liao, Hsiao-Wei; CHING-HUNG LIN ; SUNG-CHUN TANG ; CHING-HUA KUO | Analytica Chimica Acta | 6 | 5 | |
12 | 2022 | Development of an efficient mAb quantification assay by LC-MS/MS using rapid on-bead digestion | Chiu, Huai-Hsuan; Tsai, Yun-Jung; Chiao Lo ; CHING-HUNG LIN ; Tsai, I-Lin; CHING-HUA KUO | Analytica Chimica Acta | 5 | 5 | |
13 | 2022 | HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis | Tan R.S.Y.C.; Ong W.S.; Lee K.-H.; Lim A.H.; Park S.; Park Y.H.; CHING-HUNG LIN ; YEN-SHEN LU ; Ono M.; Ueno T.; Naito Y.; Onishi T.; Lim G.-H.; Tan S.-M.; Lee H.-B.; Ryu H.S.; Han W.; Tan V.K.M.; Wong F.-Y.; Im S.-A.; Tan P.H.; Chan J.Y.; Yap Y.-S. | BMC Medicine | 62 | 41 | |
14 | 2022 | The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis – A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up | Chang C.-H.; Jung C.-J.; Huang Y.-M.; Chiao L.; YIH-LEONG CHANG ; SONG-CHOU HSIEH ; CHING-HUNG LIN ; YU-MIN KUO | Breast | 5 | 5 | |
15 | 2022 | Risk Factors for Female Breast Cancer: A Population Cohort Study | Wang Y.-C.; CHING-HUNG LIN ; Huang S.-P.; Chen M.; Lee T.-S. | Cancers | 4 | 5 | |
16 | 2021 | Anti-HER2 antibody prolongs overall survival disproportionally more than progression-free survival in HER2-Positive metastatic breast cancer patients | I-CHUN CHEN ; Hu, Fu-Chang; CHING-HUNG LIN ; Huang, Shu-Min; DWANG-YING CHANG ; ANN-LII CHENG ; YEN-SHEN LU | Breast (Edinburgh, Scotland) | 2 | 2 | |
17 | 2021 | High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East Asia | LIN, CHING-HUNG ; RUBY YUN-JU HUANG ; TZU-PIN LU ; KUAN-TING KUO ; Lo, Ko-Yun; Chen, Ching-Hsuan; I-CHUN CHEN ; YEN-SHEN LU ; ERIC YAO-YU CHUANG ; Thiery, Jean Paul; CHIUN-SHENG HUANG ; ANN-LII CHENG | NPJ breast cancer | 4 | 4 | |
18 | 2021 | The Impact of COVID-19 on Cancer Care in the Post Pandemic World: Five Major Lessons Learnt from Challenges and Countermeasures of Major Asian Cancer Centres | Gatellier, Laureline; Shankar, Abhishek; Dewi, Luh K Mela; Hussain, Quazi Mushtaq; Dendup Wangdi, Tashi; Sukumaran, Dato Babu; Sari, Nina Kemala; Tavakkoli Shiraji, Sahar; Biglari, Mohammad; Tahmasebi, Mamak; Iwata, Satoshi; Suzuki, Tatsuya; Myung, Seung-Kwon; Chun, June Young; Han, Jong Soo; Lau, Fen Nee; Yusak, Suhana; Bayarsaikhan, Luvsandorj; Mu, Khin Thin; Pradhananga, Kishore K; Yusuf, Aasim; CHING-HUNG LIN ; Chiang, Ruru Chun-Ju; Sangrajran, Suleeporn; Nguyen, Quang Tien; Huong, Giang Nguyen; Soe, Aung Naing; Sharma, D N; Sengar, Manju; Pramesh, C S; Matsuda, Tomohiro; Jarrahi, Alireza Mosavi; Hwang, William | Asian Pacific journal of cancer prevention : APJCP | 9 | 0 | |
19 | 2021 | Tumor-infiltrating lymphocyte abundance and programmed death-ligand 1 expression in metaplastic breast carcinoma: implications for distinct immune microenvironments in different metaplastic components | HUANG-CHUN LIEN ; Lee Y.-H.; I-CHUN CHEN ; CHING-HUNG LIN ; WEI-WU CHEN ; Lu Y.-T.; YEN-SHEN LU | Virchows Archiv | 15 | 13 | |
20 | 2020 | Investigating the association of the biogenic amine profile in urine with therapeutic response to neoadjuvant chemotherapy in breast cancer patients | CHIUN-SHENG HUANG ; CHING-HUA KUO ; Chiao Lo ; Hsu, Ya-Lin; Cheng, Chih-Ning; CHING-HUNG LIN ; Kuo, Han-Chun | Journal of Proteome Research | 3 | 2 | |
21 | 2020 | 乳癌病人營養建議 | Tz-Ting, Huang; CHING-HUNG, LIN ; Ming-Feng, Hou; Meng-Chuan, Huang | 台灣營養學會雜誌 | 0 | ||
22 | 2020 | ERα-related chromothripsis enhances concordant gene transcription on chromosome 17q11.1-q24.1 in luminal breast cancer | Lin C.-L.; Tan X.; Chen M.; Kusi M.; Hung C.-N.; Chou C.-W.; Hsu Y.-T.; Wang C.-M.; Kirma N.; Chen C.-L.; CHING-HUNG LIN ; Lathrop K.I.; Elledge R.; Kaklamani V.G.; Mitsuya K.; Huang T.H.-M. | BMC Medical Genomics | 6 | 5 | |
23 | 2020 | Disparity in Tumor Immune Microenvironment of Breast Cancer and Prognostic Impact: Asian Versus Western Populations | Chen C.-H.; YEN-SHEN LU ; ANN-LII CHENG ; CHIUN-SHENG HUANG ; WEN-HUNG KUO ; Wang M.-Y.; Chao M.; I-CHUN CHEN ; Kuo C.-W.; TZU-PIN LU ; CHING-HUNG LIN | Oncologist | 32 | 32 | |
24 | 2020 | Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival | WEI-WU CHEN ; I-SHIOW JAN ; DWANG-YING CHANG ; CHING-HUNG LIN ; I-CHUN CHEN ; Chen H.-M.; ANN-LII CHENG ; YEN-SHEN LU | Journal of Neuro-Oncology | 17 | 13 | |
25 | 2020 | A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese women | Lien, Guang-Wen; WU-SHIUN HSIEH ; WEN-HUNG KUO ; CHING-HUA KUO ; Huang, Ching-Chun; YUE-LIANG GUO; DWANG-YING CHANG ; YEN-SHEN LU ; CHIUN-SHENG HUANG ; ANN-LII CHENG ; CHING-HUNG LIN ; PAU-CHUNG CHEN | Environment International | 49 | 35 | |
26 | 2020 | Using post-column infused internal standard assisted quantitative metabolomics for establishing prediction models for breast cancer detection | Huang M.; HUNG-YUAN LI ; Liao H.-W.; CHING-HUNG LIN ; Wang C.-Y.; WEN-HUNG KUO ; CHING-HUA KUO | Rapid Communications in Mass Spectrometry | 6 | 4 | |
27 | 2020 | Author Correction: Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models (Scientific Reports, (2019), 9, 1, (10898), 10.1038/s41598-019-45319-4) | Kuo, C.-T.; Chen, C.-L.; Li, C.-C.; Huang, G.-S.; Ma, W.-Y.; Hsu, W.-F.; CHING-HUNG LIN ; YEN-SHEN LU ; ANDREW WO | Scientific Reports | 0 | 0 | |
28 | 2020 | Response to Sung, Rosenberg, and Yang | CHING-HUNG LIN ; Yap Y.S.; Lee K.-H.; Yeo W.; Ueno T.; Li H.; Huang S.-M.; YEN-SHEN LU | Journal of the National Cancer Institute | 0 | 0 | |
29 | 2020 | Mortality of Pregnancy Following Breast Cancer Diagnoses in Taiwanese Women | Chuang S.-C.; CHING-HUNG LIN ; YEN-SHEN LU ; Hsiung C.A. | Oncologist | 3 | 4 | |
30 | 2019 | Treating HR+/HER2− breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression | Yeo W.; Ueno T.; CHING-HUNG LIN ; Liu Q.; Lee K.-H.; Leung R.; Naito Y.; Park Y.H.; Im S.-A.; Li H.; Yap Y.S.; YEN-SHEN LU ; The Asian Breast Cancer Cooperative Group | Breast Cancer Research and Treatment | 29 | 27 | |
31 | 2019 | Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models | Kuo C.-T.; Chen C.-L.; Li C.-C.; Huang G.-S.; Ma W.-Y.; Hsu W.-F.; CHING-HUNG LIN ; YEN-SHEN LU ; ANDREW WO | Scientific Reports | 6 | 5 | |
32 | 2019 | Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population | CHING-HUNG LIN ; Yap Y.S.; Lee K.-H.; Im S.-A.; Naito Y.; Yeo W.; Ueno T.; Kwong A.; Li H.; Huang S.-M.; Leung R.; Han W.; Tan B.; Hu F.-C.; CHIUN-SHENG HUANG ; ANN-LII CHENG ; YEN-SHEN LU ; Asian Breast Cancer Cooperative Group | Journal of the National Cancer Institute | 82 | 73 | |
33 | 2019 | Insights into Breast Cancer in the East vs the West: A Review | Yap Y.-S.; YEN-SHEN LU ; Tamura K.; Lee J.E.; Ko E.Y.; Park Y.H.; Cao A.-Y.; CHING-HUNG LIN ; Toi M.; Wu J.; Lee S.-C. | JAMA Oncology | 87 | 66 | |
34 | 2018 | Development of a general method for quantifying IgG-based therapeutic monoclonal antibodies in human plasma using protein G purification coupled with a two internal standard calibration strategy using LC-MS/MS | Chiu, Huai Hsuan; Liao, Hsiao Wei; YU-YUN SHAO ; YEN-SHEN LU ; CHING-HUNG LIN ; Tsai, I. Lin; CHING-HUA KUO | Analytica Chimica Acta | 49 | 45 | |
35 | 2018 | Imaging biomarkers from multiparametric magnetic resonance imaging are associated with survival outcomes in patients with brain metastases from breast cancer | BANG-BIN CHEN ; YEN-SHEN LU ; CHIH-WEI YU ; CHING-HUNG LIN ; WEI-WU CHEN ; Wei S.-Y.; ANN-LII CHENG ; TIFFANY TING-FANG SHIH | European Radiology | 9 | 9 | |
36 | 2018 | Adiposity, inflammation, and breast cancer pathogenesis in Asian Women | Iyengar N.M.; I-CHUN CHEN ; Zhou X.K.; Giri D.D.; Falcone D.J.; Winston L.A.; Wang H.; Williams S.; YEN-SHEN LU ; Hsueh T.-H.; ANN-LII CHENG ; Hudis C.A.; CHING-HUNG LIN ; Dannenberg A.J. | Cancer Prevention Research | 34 | 30 | |
37 | 2018 | A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer | WEI-WU CHEN ; Yeh D.-C.; Chao T.-Y.; CHING-HUNG LIN ; Chow L.W.-C.; DWANG-YING CHANG ; Hsieh Y.-Y.; Huang S.-M.; ANN-LII CHENG ; YEN-SHEN LU ; Taiwan Breast Cancer Consortium | Japanese Journal of Clinical Oncology | 4 | 3 | |
38 | 2018 | Rebuttal comments on “Glucocorticoids in breast cancer treatment: Real benefit or selection bias?” | CHING-HUNG LIN ; Tang C.-H. | Breast Cancer Research and Treatment | 0 | 0 | |
39 | 2018 | Effect of glucocorticoid use on survival in patients with stage I–III breast cancer | CHING-HUNG LIN ; Chuang P.-Y.; You S.-L.; CHUN-JU CHIANG ; CHIUN-SHENG HUANG ; Wang M.-Y.; Chao M.; YEN-SHEN LU ; ANN-LII CHENG ; Tang C.-H. | Breast Cancer Research and Treatment | 8 | 8 | |
40 | 2018 | Association of pregnancy and mortality in women diagnosed with breast cancer: A Nationwide Population Based Study in Taiwan | Chuang S.-C.; CHING-HUNG LIN ; YEN-SHEN LU ; Hsiung C.A. | International Journal of Cancer | 10 | 9 | |
41 | 2017 | Phosphatidylinositol-3 Kinase Inhibitors, Buparlisib and Alpelisib, Sensitize Estrogen Receptor-positive Breast Cancer Cells to Tamoxifen | I-CHUN CHEN ; Hsiao L.-P.; Huang I.-W.; Yu H.-C.; Yeh L.-C.; CHING-HUNG LIN ; Wei-Wu Chen T.; ANN-LII CHENG ; YEN-SHEN LU | Scientific Reports | 23 | 20 | |
42 | 2017 | Development of an LC-MS/MS method with protein G purification strategy for quantifying bevacizumab in human plasma | Chiu H.-H.; Tsai I.-L.; YEN-SHEN LU ; CHING-HUNG LIN ; CHING-HUA KUO | Analytical and Bioanalytical Chemistry | 20 | 15 | |
43 | 2017 | Development of a Postcolumn Infused-Internal Standard Liquid Chromatography Mass Spectrometry Method for Quantitative Metabolomics Studies | Liao H.-W.; GUAN-YUAN CHEN ; MING-SHIANG WU ; WEI-CHIH LIAO ; CHING-HUNG LIN ; CHING-HUA KUO | Journal of Proteome Research | 12 | 10 | |
44 | 2017 | Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer | SUNG-HSIN KUO ; Yang S.-Y.; You S.-L.; HUANG-CHUN LIEN ; CHING-HUNG LIN ; PO-HAN LIN ; CHIUN-SHENG HUANG | Oncotarget | 35 | 30 | |
45 | 2016 | DNA methyltransferase inhibition restores erythropoietin production in fibrotic murine kidneys | Chang, Yu-Ting; Yang, Ching-Chin; SZU-YU PAN ; YU-HSIANG CHOU ; FAN-CHI CHANG ; CHUN-FU LAI ; Tsai, Ming-Hsuan; Hsu, Huan-Lun; CHING-HUNG LIN ; WEN-CHIH CHIANG ; MING-SHIOU WU ; TZONG-SHINN CHU ; YUNG-MING CHEN ; SHUEI-LIONG LIN | The Journal of clinical investigation | 68 | 59 | |
46 | 2016 | Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer | PO-HAN LIN ; WEN-HUNG KUO ; Huang A.-C.; YEN-SHEN LU ; CHING-HUNG LIN ; SUNG-HSIN KUO ; Wang M.-Y.; Liu C.-Y.; Cheng F.T.-F.; Yeh M.-H.; Li H.-Y.; Yang Y.-H.; Hsu Y.-H.; Fan S.-C.; Li L.-Y.; SUNG-LIANG YU ; KING-JEN CHANG ; PEI-LUNG CHEN ; YEN-HSUAN NI ; CHIUN-SHENG HUANG | Oncotarget | 74 | 64 | |
47 | 2016 | Bevacizumab might potentiate the chemotherapeutic effect in breast cancer patients with leptomeningeal carcinomatosis | I-CHUN CHEN ; CHING-HUNG LIN ; I-SHIOW JAN ; ANN-LII CHENG ; YEN-SHEN LU | Journal of the Formosan Medical Association | 18 | 11 | |
48 | 2016 | Clinical Relevance of Liver Kinase B1(LKB1) Protein and Gene Expression in Breast Cancer | I-CHUN CHEN ; Chang Y.-C.; YEN-SHEN LU ; KUEI-PIN CHUNG ; CHIUN-SHENG HUANG ; TZU-PIN LU ; WEN-HUNG KUO ; Wang M.-Y.; KUAN-TING KUO ; Wu P.-F.; Hsueh T.-H.; Shen C.-Y.; CHING-HUNG LIN ; ANN-LII CHENG | Scientific Reports | 18 | 17 | |
49 | 2016 | Tailor the adjuvant hormonal manipulation for premenopausal breast cancer patients | WEI-WU CHEN ; CHING-HUNG LIN ; YEN-SHEN LU | Translational Cancer Research | 0 | 0 | |
50 | 2016 | Should pertuzumab be used as part of neoadjuvant treatment prior to the release of the APHINITY trial results? | WEI-WU CHEN ; CHING-HUNG LIN ; CHIUN-SHENG HUANG | Translational Cancer Research | 1 | 1 | |
51 | 2016 | A pilot study to determine the timing and effect of bevacizumab on vascular normalization of metastatic brain tumors in breast cancer | BANG-BIN CHEN ; YEN-SHEN LU ; CHING-HUNG LIN ; WEI-WU CHEN ; Wu P.-F.; CHAO-YU HSU ; CHIH-WEI YU ; Wei S.-Y.; ANN-LII CHENG ; TIFFANY TING-FANG SHIH | BMC Cancer | 20 | 17 | |
52 | 2015 | Associations between medical conditions and breast cancer risk in asians: A nationwide population-based study in Taiwan | Chuang S.-C.; Wu G.-J.; YEN-SHEN LU ; CHING-HUNG LIN ; Hsiung C.A. | PLoS ONE | 28 | 27 | |
53 | 2015 | A Novel 96well-formatted Micro-gap Plate Enabling Drug Response Profiling on Primary Tumour Samples | Ma, W.-Y.; Hsiung, L.-C.; Wang, C.-H.; Chiang, C.-L.; CHING-HUNG LIN ; CHIUN-SHENG HUANG ; ANDREW WO | Scientific Reports | 22 | 19 | |
54 | 2015 | Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart | Chang C.; CHING-HUNG LIN ; ANN-LII CHENG ; Medeiros L.J.; Chang K.-C. | Histopathology | 23 | 23 | |
55 | 2015 | High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country | CHING-HUNG LIN ; Shen C.-Y.; JIH-HSIANG LEE ; CHIUN-SHENG HUANG ; CHIH-HSIN YANG ; WEN-HUNG KUO ; DWANG-YING CHANG ; Hsiung C.-N.; KUAN-TING KUO ; WEI-WU CHEN ; I-CHUN CHEN ; Wu P.-F.; SUNG-HSIN KUO ; Chen C.-J.; YEN-SHEN LU ; ANN-LII CHENG | PLoS ONE | 10 | 6 | |
56 | 2015 | TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays | CHING-HUNG LIN ; Chen I.-C.; CHIUN-SHENG HUANG ; Hu F.-C.; WEN-HUNG KUO ; KUAN-TING KUO ; Wang C.-C.; Wu P.-F.; DWANG-YING CHANG ; Wang M.-Y.; Chang C.-H.; WEI-WU CHEN ; YEN-SHEN LU ; ANN-LII CHENG | Scientific Reports | 10 | 11 | |
57 | 2015 | Bevacizumab preconditioning followed by etoposide and cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapy | YEN-SHEN LU ; WEI-WU CHEN ; CHING-HUNG LIN ; Yeh D.-C.; Tseng L.-M.; Wu P.-F.; Rau K.-M.; BANG-BIN CHEN ; Chao T.-C.; Huang S.-M.; CHIUN-SHENG HUANG ; TIFFANY TING-FANG SHIH ; ANN-LII CHENG ; Taiwan Breast Cancer Consortium | Clinical Cancer Research | 65 | 59 | |
58 | 2015 | A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis | Wu P.-F.; CHING-HUNG LIN ; CHING-HUA KUO ; WEI-WU CHEN ; Yeh D.-C.; Liao H.-W.; Huang S.-M.; ANN-LII CHENG ; YEN-SHEN LU | BMC Cancer | 48 | 36 | |
59 | 2014 | A spatiotemporally defined in vitro microenvironment for controllable signal delivery and drug screening | Kuo, C.-T.; Liu, H.-K.; Huang, G.-S.; Chang, C.-H.; Chen, C.-L.; Chen, K.-C.; RUBY YUN-JU HUANG ; CHING-HUNG LIN ; Lee, H.; CHIUN-SHENG HUANG ; ANDREW WO | Analyst | 16 | 14 | |
60 | 2014 | No increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifen | WEI-WU CHEN ; Chen H.-M.; CHING-HUNG LIN ; CHIUN-SHENG HUANG ; ANN-LII CHENG ; Lai M.-S.; YEN-SHEN LU | Breast Cancer Research and Treatment | 10 | 8 | |
61 | 2014 | Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an east Asian country: A nationwide cancer registry-based study | CHING-HUNG LIN ; Chuang P.-Y.; CHUN-JU CHIANG ; YEN-SHEN LU ; ANN-LII CHENG ; WEN-HUNG KUO ; CHIUN-SHENG HUANG ; Lai M.-S.; You S.-L.; Tang C.-H. | Oncologist | 39 | 39 | |
62 | 2014 | Quantification of target analytes in various biofluids using a postcolumn infused-internal standard method combined with matrix normalization factors in liquid chromatography-electrospray ionization mass spectrometry | Liao H.-W.; Tsai I.-L.; GUAN-YUAN CHEN ; YEN-SHEN LU ; CHING-HUNG LIN ; CHING-HUA KUO | Journal of Chromatography A | 12 | 12 | |
63 | 2014 | Chromosome 20q13.2 ZNF217 locus amplification correlates with decreased E-cadherin expression in ovarian clear cell carcinoma with PI3K-Akt pathway alterations | Huang H.-N.; Huang W.-C.; CHING-HUNG LIN ; YING-CHENG CHIANG ; Huang H.-Y.; KUAN-TING KUO | Human Pathology | 21 | 20 | |
64 | 2014 | Differential expression of hyaluronan synthase 2 in breast carcinoma and its biological significance | HUANG-CHUN LIEN ; Lee Y.-H.; YUNG-MING JENG ; CHING-HUNG LIN ; YEN-SHEN LU ; Yao Y.-T. | Histopathology | 33 | 28 | |
65 | 2013 | Distant metastasis in triple-negative breast cancer | Tseng L.M.; Hsu N.C.; Chen S.C.; YEN-SHEN LU ; CHING-HUNG LIN ; DWANG-YING CHANG ; Li H.; Lin Y.C.; Chang H.K.; Chao T.C.; Ouyang F.; Hou M.F. | Neoplasma | 95 | 85 | |
66 | 2013 | Differential expression of ubiquitin carboxy-terminal hydrolase L1 in breast carcinoma and its biological significance | HUANG-CHUN LIEN ; Wang C.-C.; CHING-HUNG LIN ; YEN-SHEN LU ; CHIUN-SHENG HUANG ; Hsiao L.-P.; Yao Y.-T. | Human Pathology | 12 | 12 | |
67 | 2013 | The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines | WEI-WU CHEN ; DWANG-YING CHANG ; Huang S.-M.; CHING-HUNG LIN ; CHIUN HSU ; Lin M.-H.; CHIUN-SHENG HUANG ; YEN-SHEN LU ; ANN-LII CHENG | Breast | 4 | 5 | |
68 | 2013 | Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas | Wu P.-F.; Huang W.-C.; CHIH-HSIN YANG ; YEN-SHEN LU ; JIN-YUAN SHIH ; SHANG-GIN WU ; CHING-HUNG LIN ; ANN-LII CHENG | Journal of Neuro-Oncology | 8 | 5 | |
69 | 2013 | Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation | CHING-HUNG LIN ; Liu J.M.; YEN-SHEN LU ; Lan C.; Lee W.-C.; KUAN-TING KUO ; Wang C.-C.; DWANG-YING CHANG ; CHIUN-SHENG HUANG ; ANN-LII CHENG | Journal of Clinical Pathology | 13 | 14 | |
70 | 2013 | CYP19 genetic polymorphism haplotype aasa is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer | SUNG-HSIN KUO ; Yang, Shi-Yi; HUANG-CHUN LIEN ; Chiao Lo ; CHING-HUNG LIN ; YEN-SHEN LU ; ANN-LII CHENG ; KING-JEN CHANG ; CHIUN-SHENG HUANG | BioMed Research International | 9 | 9 | |
71 | 2012 | Enumeration and viability of rare cells in a microfluidic disk via positive selection approach | Chen, K.-C.; Pan, Y.-C.; Chen, C.-L.; CHING-HUNG LIN ; CHIUN-SHENG HUANG ; ANDREW WO | Analytical Biochemistry | 9 | 10 | |
72 | 2012 | Clinicopathological features of salivary and non-salivary adenoid cystic carcinomas | Lin Y.-C.; Chen K.-C.; CHING-HUNG LIN ; KUAN-TING KUO ; JENG-YUH KO ; RUEY-LONG HONG | International Journal of Oral and Maxillofacial Surgery | 22 | 19 | |
73 | 2012 | Hashimoto's encephalopathy as the cause of deteriorating consciousness during treatment of leptomeningeal carcinomatosis from breast cancer | YI-HSIN LIANG ; Wu P.-F.; CHING-HUNG LIN ; YEN-SHEN LU | Journal of Clinical Oncology | 0 | 0 | |
74 | 2012 | Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy | Kuo Y.-H.; CHING-HUNG LIN ; Shau W.-Y.; Chen T.-J.; SHIH-HUNG YANG ; Huang S.-M.; CHIUN HSU ; YEN-SHEN LU ; ANN-LII CHENG | BMC Cancer | 19 | 16 | |
75 | 2012 | Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancer | WEN-HUNG KUO ; PO-HAN LIN ; Huang A.-C.; YIN-HSIU CHIEN ; Liu T.-P.; YEN-SHEN LU ; Bai L.-Y.; Sargeant A.M.; CHING-HUNG LIN ; ANN-LII CHENG ; FON-JOU HSIEH ; WUH-LIANG HWU ; KING-JEN CHANG | Journal of Human Genetics | 19 | 19 | |
76 | 2012 | The emerging epidemic of estrogen-related cancers in young women in a developing Asian country | CHING-HUNG LIN ; Chen Y.-C.; CHUN-JU CHIANG ; YEN-SHEN LU ; KUAN-TING KUO ; CHIUN-SHENG HUANG ; WEN-FANG CHENG ; Lai M.-S.; You S.-L.; ANN-LII CHENG | International Journal of Cancer | 47 | 45 | |
77 | 2011 | Axillary vs sentinel lymph node dissectionfor invasive breast cancer [2] | I-CHUN CHEN ; CHING-HUNG LIN ; YEN-SHEN LU | JAMA - Journal of the American Medical Association | 9 | 4 | |
78 | 2011 | Separation and detection of rare cells in a microfluidic disk via negative selection | Chen, C.-L.; Chen, K.-C.; Pan, Y.-C.; Lee, T.-P.; Hsiung, L.-C.; Lin, C.-M.; Chen, C.-Y.; CHING-HUNG LIN ; BOR-LUEN CHIANG ; ANDREW WO | Lab on a Chip | 66 | 64 | |
79 | 2011 | Estrogen-mediated epigenetic repression of the imprinted gene cyclin-dependent kinase inhibitor 1C in breast cancer cells | Rodriguez B.A.T.; Weng Y.-I.; Liu T.-M.; Zuo T.; Hsu P.-Y.; CHING-HUNG LIN ; ANN-LII CHENG ; Cui H.; Yan P.S.; Huang T.H.-M. | Carcinogenesis | 40 | 35 | |
80 | 2011 | Prognostic molecular markers in Women aged 35 years or younger with breast cancer: Is there a difference from the older patients? | CHING-HUNG LIN ; YEN-SHEN LU ; CHIUN-SHENG HUANG ; KUAN-TING KUO ; Wang C.-C.; You S.-L.; PO-HAN LIN ; DWANG-YING CHANG ; WEN-HUNG KUO ; KING-JEN CHANG ; ANN-LII CHENG | Journal of Clinical Pathology | 8 | 8 | |
81 | 2011 | The Association of Infrared Imaging Findings of the Breast with Hormone Receptor and Human Epidermal Growth Factor Receptor 2 Status of Breast Cancer | JANE WANG ; TIFFANY TING-FANG SHIH ; RUOH-FANG YEN ; YEN-SHEN LU ; Chen C.-Y.; TSUI-LIEN MAO ; CHING-HUNG LIN ; WEN-HUNG KUO ; Tsai Y.-S.; KING-JEN CHANG ; KUO-LIONG CHIEN | Academic Radiology | 10 | 7 | |
82 | 2011 | Dielectrophoresis-based cellular microarray chip for anticancer drug screening in perfusion microenvironments | Hsiung, L.-C.; Chiang, C.-L.; Wang, C.-H.; Huang, Y.-H.; Kuo, C.-T.; Cheng, J.-Y.; CHING-HUNG LIN ; Wu, V.; Chou, H.-Y.; Jong, D.-S.; Lee, H.; ANDREW WO | Lab on a Chip | 50 | 45 | |
83 | 2011 | Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era | I-CHUN CHEN ; CHING-HUNG LIN ; CHIUN-SHENG HUANG ; HUANG-CHUN LIEN ; CHIUN HSU ; WEN-HUNG KUO ; YEN-SHEN LU ; ANN-LII CHENG | Breast Cancer Research and Treatment | 87 | 74 | |
84 | 2010 | Separation and detection of rare cells via multistage magnetic gradient in a microfluidic disk | Chen C.-L.; Chen K.-C.; Pan Y.-C.; Lee T.-P.; Yang C.-W.; Hsiung L.-C.; Lin C.-M.; Chen C.-Y.; CHING-HUNG LIN ; BOR-LUEN CHIANG ; Wo A.M. | 14th International Conference on Miniaturized Systems for Chemistry and Life Sciences 2010, MicroTAS 2010 | 0 | ||
85 | 2010 | Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cells | Weng Y.-I.; Hsu P.-Y.; Liyanarachchi S.; Liu J.; Deatherage D.E.; Huang Y.-W.; Zuo T.; Rodriguez B.; CHING-HUNG LIN ; ANN-LII CHENG ; Huang T.H.-M. | Toxicology and Applied Pharmacology | 108 | 87 | |
86 | 2010 | Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapy | CHING-HUNG LIN ; HUANG-CHUN LIEN ; Hu F.-C.; YEN-SHEN LU ; SUNG-HSIN KUO ; Wu L.-C.; You S.-L.; ANN-LII CHENG ; KING-JEN CHANG ; CHIUN-SHENG HUANG | Journal of Zhejiang University: Science B | 8 | 11 | |
87 | 2010 | Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin | YU-YUN SHAO ; KUAN-TING KUO ; Hu F.-C.; YEN-SHEN LU ; CHIUN-SHENG HUANG ; JAU-YU LIAU ; Lee W.-C.; CHIUN HSU ; WEN-HUNG KUO ; KING-JEN CHANG ; CHING-HUNG LIN ; ANN-LII CHENG | Japanese Journal of Clinical Oncology | 28 | 24 | |
88 | 2010 | Unique features of breast cancer in Asian women-Breast cancer in Taiwan as an example | CHIUN-SHENG HUANG ; CHING-HUNG LIN ; YEN-SHEN LU ; Shen C.-Y. | Journal of Steroid Biochemistry and Molecular Biology | 42 | 44 | |
89 | 2010 | O6-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers | PEI-FANG WU; KUAN-TING KUO ; LU-TING KUO ; YI-TING LIN; WEI-CHUNG LEE; YEN-SHEN LU ; CHIH-HSIN YANG ; RUEY-MEEI WU ; YONG-KWANG TU ; JUI-CHANG TASI ; HAM-MIN TSENG; SHENG-HONG TSENG ; ANN-LII CHENG ; CHING-HUNG LIN | Lung Cancer | 26 | 26 | |
90 | 2010 | Vinorelbine plus 24-hour infusion of high-dose 5-fluorouracil and leucovorin as effective palliative chemotherapy for breast cancer patients with acute disseminated intravascular coagulation | PO-HAN LIN ; YEN-SHEN LU ; CHING-HUNG LIN ; DWANG-YING CHANG ; CHIUN-SHENG HUANG ; ANN-LII CHENG ; KUN-HUEI YEH | Anticancer Research | 6 | 4 | |
91 | 2009 | Locoregional therapy improves survival for metastatic breast cancer patients? Benefit remains questionable! | DWANG-YING CHANG ; CHING-HUNG LIN ; YEN-SHEN LU | Journal of Clinical Oncology | 2 | 1 | |
92 | 2009 | Molecular subtypes of breast cancer emerging in young women in Taiwan: Evidence for more than just westernization as a reason for the disease in Asia | CHING-HUNG LIN ; JAU-YU LIAU ; YEN-SHEN LU ; CHIUN-SHENG HUANG ; Lee W.-C.; KUAN-TING KUO ; Ying-Chun Shen ; SUNG-HSIN KUO ; Lan C.; Liu J.M.; WEN-HUNG KUO ; KING-JEN CHANG ; ANN-LII CHENG | Cancer Epidemiology Biomarkers and Prevention | 101 | 95 | |
93 | 2008 | The biomarkers of human papillomavirus infection in tonsillar squamous cell carcinoma - Molecular basis and predicting favorable outcome | KUAN-TING KUO ; Hsiao C.-H.; CHING-HUNG LIN ; LU-TING KUO ; Huang S.-H.; Lin M.-C. | Modern Pathology | 77 | 66 | |
94 | 2008 | The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers | CHIUN-SHENG HUANG ; SUNG-HSIN KUO ; HUANG-CHUN LIEN ; Yang S.-Y.; You S.-L.; Shen C.-Y.; CHING-HUNG LIN ; YEN-SHEN LU ; KING-JEN CHANG | Oncologist | 19 | 18 | |
95 | 2008 | Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients | SUNG-HSIN KUO ; HUANG-CHUN LIEN ; You S.-L.; YEN-SHEN LU ; CHING-HUNG LIN ; Chen T.-Z.; CHIUN-SHENG HUANG | Breast | 13 | 12 | |
96 | 2008 | A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline | RUEY-LONG HONG ; CHING-HUNG LIN ; Chao T.-Y.; Kao W.-Y.; Wang C.-H.; Hsieh R.K.; Hwang W.-S. | Cancer Chemotherapy and Pharmacology | 9 | 7 | |
97 | 2008 | Breast cancer-associated fibroblasts confer AKT1-mediated epigenetic silencing of Cystatin M in epithelial cells | Lin H.-J.L.; Zuo T.; CHING-HUNG LIN ; Chieh T.K.; Liyanarachchi S.; Sun S.; Shen R.; Deatherage D.E.; Potter D.; Asamoto L.; Lin S.; Yan P.S.; ANN-LII CHENG ; Ostrowski M.C.; Huang T.H.-M. | Cancer Research | 58 | 55 | |
98 | 2006 | Downregulation of BRG-1 repressed expression of CD44s in cervical neuroendocrine carcinoma and adenocarcinoma | KUAN-TING KUO ; Liang C.-W.; Hsiao C.-H.; CHING-HUNG LIN ; CHI-AN CHEN ; BOR-CHING SHEU ; Lin M.-C. | Modern Pathology | 18 | 16 | |
99 | 2006 | Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system origin and peripheral nodal origin | CHING-HUNG LIN ; KUAN-TING KUO ; Chuang S.-S.; SUNG-HSIN KUO ; Chang J.H.; Chang K.-C.; Hsu H.-C.; HWEI-FANG TIEN ; ANN-LII CHENG | Clinical Cancer Research | 111 | 95 | |
100 | 2005 | Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylate | CHING-HUNG LIN ; RUOH-FANG YEN ; YUNG-MING JENG ; Tzen C.-Y.; CHIUN HSU ; RUEY-LONG HONG | Head and Neck | 40 | 30 | |
101 | 2005 | 原發性中樞神經系統淋巴瘤之研究 | 林璟宏; Lin, Ching-Hung |